Erin VanDyke: Shifting Attention Upstream in VTE Care Through NBCA Centers of Excellence
Erin VanDyke, Vice President of National Blood Clot Alliance Centers of Excellence, shared a post on LinkedIn:
“Pulmonary embolism (PE) often takes the spotlight in venous thromboembolism (VTE) discussions, and understandably so—it is frequently life-threatening. But the most common precursor to PE is deep vein thrombosis (DVT), and this is where we have a real opportunity to intervene earlier.
- Up to 50% of patients with PE also have concomitant DVT
- An estimated 900,000 Americans are affected by VTE each year, with 100,000+ deaths annually—many preventable
Despite these numbers, resources and infrastructure to support DVT identification, follow-up, and longitudinal care remain limited compared to PE. Clinical pathways vary widely, and standardized approaches are often lacking.
National Blood Clot Alliance is leading national efforts across the full VTE disease state—PE and DVT alike. Through initiatives like the NBCA Centers of Excellence program, we are partnering with hospitals and clinical teams to:
- Standardize care protocols
- Strengthen follow-up pathways
- Provide education and resources that support providers and patients across the spectrum of VTE
We encourage centers to explore the NBCA COE program and stay tuned for new initiatives launching to support community DVT centers.
Our collective challenge—and opportunity—is to shift attention upstream. By addressing DVT earlier and more consistently, we can reduce downstream PE and ultimately save lives.”
More information here.
Keep up with Hemostasis Today.
-
Oct 21, 2025, 06:59Samwel Mikaye: Polycythemia and the Risk of Blood Clots
-
Oct 21, 2025, 06:58Samuel Nweke: Interpreting D-Dimer Results
-
Oct 21, 2025, 05:20Ewa Fiorentino Rozek: APS - When “Unprovoked” Clots And Pregnancy Loss Connect
-
Oct 21, 2025, 03:503 Questions With Abigail Ajanel Gomez – Touch Haematology Future Leader 2025
-
Oct 21, 2025, 01:57Mohamed Reda: Clotting Factors — The Key Players in Blood Coagulation
-
Oct 21, 2025, 11:13Hanny Al Samkari's Commentary on Iron Deficiency Anemia in Inherited Bleeding Disorders
-
Oct 21, 2025, 11:08Wolfgang Miesbach on New Real-World Data for Haemophilia B Prophylaxis
-
Oct 21, 2025, 06:53Haitham Shedeed: The Importance of Heparin Testing Before Catheterization
-
Oct 21, 2025, 06:44Asmaa A About Pseudo Thrombocytopenia: Causes and How to Handle
-
Oct 21, 2025, 06:41Natural Anticoagulants in Focus․ Protein C and S
-
Oct 21, 2025, 06:58Arno Nierich: How Caffeine Affects Red Blood Cells and Blood Storage
-
Oct 21, 2025, 06:43Could Gene Therapy Offer Lasting Quality of Life for People with Hemophilia B?
-
Oct 21, 2025, 06:18Katerina Akassoglou Receives Zenith Fellows Award to Advance Alzheimer’s Research
-
Oct 16, 2025, 06:07ClearPlasma - A New Breakthrough in Stopping Life-Threatening Bleeds
-
Oct 14, 2025, 05:26Ryan C. Heniford: Every Thrombus Prevented Is a Patient Protected
-
Oct 21, 2025, 11:11Nana Kwame Kwabi Boateng: Grateful For The Opportunity to Serve As A SEARCH Ambassador
-
Oct 21, 2025, 05:00Sheila Cristina Ouriques Martins Is Grateful to Be Among The Legends Who Changed The Reality of Stroke Worldwide
-
Oct 21, 2025, 01:47Cathy Bliem: Yesterday, I Made My 4th Plasma Donation of 2025...
-
Oct 20, 2025, 12:40Asfand Yar Cheema: Honored to be featured in Video Journal of Hematology and Hematological Oncology
-
Oct 20, 2025, 12:25Laurent Bertoletti Highlights Evolving Role of Anticoagulation in Pulmonary Hypertension Treatment